scispace - formally typeset
M

Matias Kaplan

Researcher at Stanford University

Publications -  9
Citations -  2508

Matias Kaplan is an academic researcher from Stanford University. The author has contributed to research in topics: RNA & Cas9. The author has an hindex of 5, co-authored 6 publications receiving 2043 citations. Previous affiliations of Matias Kaplan include University of California, Berkeley.

Papers
More filters
Journal ArticleDOI

Structures of Cas9 Endonucleases Reveal RNA- Mediated Conformational Activation

TL;DR: To compare the architectures and domain organization of diverse Cas9 proteins, the atomic structures of Cas9 from Streptococcus pyogenes and Actinomyces naeslundii and AnaCas9 were determined by x-ray crystallography and three-dimensional reconstructions of apo-SpyCas9, SpyCas9:RNA, and SpyCas 9:RNA:DNA were obtained by negative-stain single-particle electron microscopy.
Journal ArticleDOI

Programmable RNA recognition and cleavage by CRISPR/Cas9

TL;DR: It is shown that Cas9 binds with high affinity to single-stranded RNA targets matching the Cas9-associated guide RNA sequence when the PAM is presented in trans as a separate DNA oligonucleotide, revealing a fundamental connection between PAM binding and substrate selection by Cas9 and highlighting the utility of Cas9 for programmable transcript recognition without the need for tags.
Journal ArticleDOI

Conformational control of DNA target cleavage by CRISPR–Cas9

TL;DR: A proofreading mechanism beyond initial protospacer adjacent motif (PAM) recognition and RNA–DNA base-pairing that serves as a final specificity checkpoint before DNA double-strand break formation is highlighted.
Journal ArticleDOI

Induction of sodium channel clustering by oligodendrocytes

TL;DR: A crucial role is demonstrated for oligodendrocytes in inducing clustering of sodium channels along axons in vitro and in vivo and the clusters are regularly spaced at the predicted interval in the absence of glial–axonal contact.
Journal ArticleDOI

Massively parallel RNA device engineering in mammalian cells with RNA-Seq.

TL;DR: A quantitative, rapid and high-throughput mammalian cell-based RNA-Seq assay to efficiently engineer ribozyme switches that respond to theophylline, hypoxanthine, cyclic-di-GMP, and folinic acid from libraries of ~22,700 sequences in total are developed.